Latest period
$1.09B
YoY change
+360.5%
5Y CAGR
+15.6%
Peak year (FY2021)
$1.4B
Latest annual
$1.34B
Free Cash Flow history chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: $1.34B
Free Cash Flow growth chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: +360.5%
Free Cash Flow history table for Edwards Lifesciences (EW) from 1999 to 2025
| FY2025 | $1.34B | +360.5% | +$1.05B | ||
| FY2024 | $290M | -53.9% | -$340M | ||
| FY2023 | $630M | -34.0% | -$324M | ||
| FY2022 | $953M | -32.0% | -$449M | ||
| FY2021 | $1.4B | +116.7% | +$755M | ||
| FY2020 | $647M | -28.2% | -$254M | ||
| FY2019 | $901M | +31.5% | +$216M | ||
| FY2018 | $685M | -17.0% | -$140M | ||
| FY2017 | $825M | +69.4% | +$338M | ||
| FY2016 | $487M | +9.9% | +$43.8M | ||
| FY2015 | $443M | -52.3% | -$485M | ||
| FY2014 | $929M | +156.1% | +$566M | ||
| FY2013 | $363M | +47.3% | +$117M | ||
| FY2012 | $246M | +9.9% | +$22.2M | ||
| FY2011 | $224M | +18.8% | +$35.5M | ||
| FY2010 | $188M | +86.0% | +$87.1M | ||
| FY2009 | $101M | +34.7% | +$26.1M | ||
| FY2008 | $75.2M | -49.1% | -$72.5M | ||
| FY2007 | $148M | -13.8% | -$23.7M | ||
| FY2006 | $171M | +94.1% | +$83.1M | ||
| FY2005 | $88.3M | -36.1% | -$49.8M | ||
| FY2004 | $138M | +63.6% | +$53.7M | ||
| FY2003 | $84.4M | +5.6% | +$4.5M | ||
| FY2002 | $79.9M | +26.8% | +$16.9M | ||
| FY2001 | $63M | -30.8% | -$28M | ||
| FY2000 | $91M | -32.1% | -$43M | ||
| FY1999 | $134M | — | — |
- FY2025$1.34B+360.5%
- FY2024$290M-53.9%
- FY2023$630M-34.0%
- FY2022$953M-32.0%
- FY2021$1.4B+116.7%
- FY2020$647M-28.2%
- FY2019$901M+31.5%
- FY2018$685M-17.0%
- FY2017$825M+69.4%
- FY2016$487M+9.9%
- FY2015$443M-52.3%
- FY2014$929M+156.1%
- FY2013$363M+47.3%
- FY2012$246M+9.9%
- FY2011$224M+18.8%
- FY2010$188M+86.0%
- FY2009$101M+34.7%
- FY2008$75.2M-49.1%
- FY2007$148M-13.8%
- FY2006$171M+94.1%
- FY2005$88.3M-36.1%
- FY2004$138M+63.6%
- FY2003$84.4M+5.6%
- FY2002$79.9M+26.8%
- FY2001$63M-30.8%
- FY2000$91M-32.1%
- FY1999$134M—
Free Cash Flow values are taken from Edwards Lifesciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Edwards Lifesciences (EW)
Free Cash Flow for Edwards Lifesciences (EW): headline value $1.09B · YoY +360.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Edwards Lifesciences (EW) came in at $1.34B – surged 360.5% year-over-year.
Edwards Lifesciences free cash flow has grown on net over the period, with a +15.6% compound annual growth rate over 2020–2025 (5 years).
Edwards Lifesciences free cash flow edged down from $1.4B in 2021 to $1.34B in 2025, a 4.8% drawdown.
Across the available history, free cash flow reached its high of $1.4B in 2021 and its low of $63M in 2001.
Edwards Lifesciences Free Cash Flow by Year
Edwards Lifesciences Free Cash Flow 2025: $1.34B
2025's free cash flow for Edwards Lifesciences came in at $1.34B, surged 360.5% from 2024.
Edwards Lifesciences Free Cash Flow 2024: $290M
Edwards Lifesciences posted free cash flow of $290M in 2024, plunged 53.9% below 2023.
Edwards Lifesciences Free Cash Flow 2023: $630M
In 2023, Edwards Lifesciences reported free cash flow of $630M, plunged 34.0% below 2022.
Edwards Lifesciences Free Cash Flow 2022: $953M
Edwards Lifesciences free cash flow in 2022 was $953M, plunged 32.0% below 2021.
Edwards Lifesciences Free Cash Flow 2021: $1.4B
Edwards Lifesciences free cash flow in 2021 was $1.4B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Free Cash Flow
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest free cash flow
| $19.7B | |
| $17.8B | |
| $16.1B | |
| $12.4B | |
| $8.97B | |
| $8.1B | |
| $6.29B | |
| $4.52B |
- $19.7B
- $17.8B
- $16.1B
- $12.4B
- $8.97B
- $8.1B
- $4.52B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.